Chlortab

Quick links to important sections

Chlortab

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Chlortab

Quick Facts

Property Description
Active ingredient Chlorphenamine Maleate
Form Tablet, syrup, oral solution
Pharmacological class First-generation H1-Antihistamine
Common use Anti-allergic agent
Origin Synthetic compound

What Type of Medicine is Chlortab? (Identity and Classification)

Chlortab is an anti-allergic pharmaceutical preparation whose active substance is Chlorphenamine Maleate, formally classified as a first-generation H1-antihistamine. This medicine acts as a histamine receptor antagonist. Chlorphenamine Maleate is a synthetic compound that belongs to the alkylamine derivative family, meaning its structure is chemically engineered to block histamine effects. This medication is utilized for its primary function of counteracting the body's physical response to allergens.


Composition and Common Forms (Structure and Availability)

The medicine contains Chlorphenamine Maleate as a single active ingredient, which is the stable maleate salt of the base compound Chlorpheniramine. This single active ingredient product is characterized by its bioavailability in various forms. It is prepared in several standard dosage forms, providing versatility. While the primary route of administration is oral, typically via a tablet, syrup, or oral solution, the compound is also available in an injectable solution for parenteral administration in clinical settings. The use of the maleate salt ensures the stability and reliable absorption of the medication.


What is the General Purpose of Chlortab? (High-Level Function)

The general purpose of Chlortab is to act as an anti-allergic agent by counteracting the unwanted effects of histamine released during the body's allergic response. It achieves this by performing antagonism of H1 receptors, a mechanism for providing relief from allergic symptoms. As a characteristic of this first-generation class, Chlortab possesses a significant lipophilicity that allows it to cross the blood-brain barrier, resulting in a sedative property that differentiates its profile from newer, non-sedating alternatives.

Regulatory References

  1. Chlorpheniramine - MeSH - NCBI (NIH)
  2. Chlorpheniramine: MedlinePlus Drug Information
  3. Chlorpheniramine Maleate: DailyMed Drug Label (NIH/FDA)

What side effects are possible with Chlortab?

Possible side effects and safety information

The official safety profile of Chlorphenamine Maleate, the active ingredient in Chlortab, is primarily defined by its effects on the central nervous system and its anticholinergic properties, as documented in regulatory sources.

Adverse Reaction Scope

Category Official Regulatory Classification/Content
Frequency Classification Very Common: Sedation and Somnolence (Drowsiness). Common: Dizziness, Headache, Disturbed attention, Dry mouth, Fatigue, Nausea.
System-Organ Classes Adverse effects are documented across the Nervous System (e.g., inattention), Gastrointestinal Disorders (e.g., dry mouth), and Eye Disorders (e.g., blurred vision).
Serious Adverse Reactions Officially documented serious safety concerns include rare occurrences of blood dyscrasias (disorders of the blood system) and severe anaphylactic reactions (hypersensitivity).

Population and Time-Related Safety

Regulatory documentation specifies that Older Adults (geriatric patients) are at an increased risk for certain adverse reactions, including confusion and the anticholinergic effect of urinary retention. Caution is advised for individuals with renal or hepatic impairment due to the potential for altered drug clearance.

Time-related patterns in the regulatory profile note that the most common effects, such as sedation and drowsiness, are more likely to occur at the beginning of treatment.

Safety-Related Restrictions: The official product labeling includes explicit caution regarding concurrent use with alcohol and other Central Nervous System (CNS) depressants, which may lead to enhanced sedation. The medicine is also restricted (contraindicated) for use in patients treated with Monoamine Oxidase Inhibitors (MAOIs).

Overdose and Emergency Response

Overdose and when to seek help

Overdose scope

Property Description
Documented overdose presentations Overdose is documented to present with signs of both Central Nervous System (CNS) depression (e.g., drowsiness, coma) and CNS excitation (e.g., agitation, convulsions, hallucinations). Anticholinergic symptoms, including mydriasis (dilated pupils), dry mouth, tachycardia, and fever, are commonly observed.
Physiological systems affected (as stated in label) CNS, Cardiovascular (arrhythmias, QRS widening), Respiratory (apnoea, depression), and Fluid/Electrolyte Balance (rhabdomyolysis).
Population-specific overdose notes (if applicable) Children are more likely to experience paradoxical excitation and seizures. The elderly exhibit increased susceptibility to CNS effects (e.g., confusion, profound sedation) and severe anticholinergic symptoms.
When immediate medical help is required (label-derived phrasing only) Seek emergency medical attention at once if an overdose is suspected. Urgent medical intervention is required for signs such as extreme sleepiness, confusion, seizures, or shallow breathing.

Overdose classifications (high-level)

Property Description
Severity classification (as defined in official documents) Overdose has the potential for life-threatening complications, including cardiac collapse, ventricular arrhythmias, and respiratory failure.
Overdose-context constraints (as defined in official documents) No specific antidote is known for the treatment of this overdose.

Official overdose statements:

  • Supportive measures include administration of activated charcoal within one hour of ingestion and the use of benzodiazepines to control convulsions or severe agitation.
  • Cardiac monitoring (ECG) should be instituted to assess for severe cardiovascular toxicity (e.g., QRS widening).

Connection to the overall overdose profile:

Regulatory documents define the Chlorphenamine Maleate overdose profile by the dual risk of severe CNS depression or excitation, which can rapidly escalate to life-threatening cardiac or respiratory crisis. The potential for these severe outcomes mandates that the ingestion of an excessive quantity requires the patient to seek emergency medical attention immediately, focusing treatment on comprehensive symptomatic and supportive care.

Therapeutic Uses of Chlortab

Uses of Chlortab

Chlortab is an antihistamine containing chlorphenamine maleate. It is primarily used to manage symptoms associated with various allergic conditions and the common cold.

Allergic Rhinitis

Chlortab is used to alleviate symptoms of allergic rhinitis, commonly known as hay fever. This condition involves inflammation of the nasal passages caused by allergens such as pollen, dust mites, or pet dander. The medication helps address several manifestations of this response, including:

  • Frequent sneezing
  • Runny or congested nose
  • Itchy or watery eyes
  • Itching of the nose or throat

Urticaria and Skin Allergies

The medication is also utilized to treat skin-related allergic reactions. It can help reduce the discomfort associated with urticaria (hives), which is characterized by itchy, raised red welts on the skin. Additionally, it may be used for other itchy skin conditions, such as allergic dermatitis or reactions to insect bites and stings.

Common Cold Symptoms

While it does not treat the underlying viral infection, Chlortab is often used to provide temporary relief from certain symptoms of the common cold. By reducing secretions and soothing irritation in the upper respiratory tract, it helps manage a runny nose and sneezing often associated with viral respiratory infections.

Other Allergic Reactions

Chlortab may be used as part of a management plan for generalized allergic reactions, including allergic conjunctivitis (eye irritation) and food allergies, to help control systemic histamine-mediated symptoms.

Regulatory References

  1. NIH MedlinePlus overview on Chlorpheniramine

Eligibility and Restrictions for Use

Who Can and Cannot Use Chlortab?

Eligibility for Chlorphenamine Maleate (Chlortab) is defined by official regulatory documentation, outlining specific populations who are prohibited from use (contraindicated) or who must use the medicine under strict conditions.


Contraindicated Populations (Absolute Ban)

Chlortab must not be used by patients with a known hypersensitivity to Chlorphenamine Maleate or any component of the formulation. It is strictly contraindicated in patients currently receiving Monoamine Oxidase Inhibitors (MAOIs) or within 14 days of stopping MAOI therapy. Use is also prohibited in patients diagnosed with narrow-angle glaucoma or conditions causing urinary retention, and in neonates or premature infants.


Eligibility Rules by Population

Population Group Regulatory Status
Children under 6 years Not recommended for standard oral formulations.
Children under 2 years Safety and efficacy not established.
Older Adults (Geriatric) Use with caution; requires special consideration and possibly a lower daily dose.
Pregnancy/Lactation Generally not recommended; risk-benefit assessment is required.

Conditional use is required for patients with severe hepatic or renal impairment, epilepsy, prostatic hypertrophy, and certain cardiovascular conditions.

What should I know about interactions with other medicines?

Chlortab (chlorpheniramine maleate) can interact with a variety of other medicines and products, which may intensify side effects, primarily drowsiness and anticholinergic effects (such as dry mouth, blurred vision, and difficulty urinating). Consult a healthcare provider or pharmacist before taking Chlortab if you are currently using any other medicines, including prescription, over-the-counter, or herbal remedies.

Major Interactions

The most significant interactions involve medicines that also cause central nervous system (CNS) depression or have anticholinergic properties. Concurrent use may lead to excessive sedation, respiratory depression, or confusion. Avoid combining Chlortab with:

  • Alcohol and other CNS depressants, including sleeping pills, sedatives, tranquilizers, and some opioid pain relievers.
  • Monoamine Oxidase Inhibitors (MAOIs), a type of antidepressant. Taking Chlortab within 14 days of an MAOI can prolong and intensify both the sedative and anticholinergic effects of Chlortab.
  • Tricyclic Antidepressants (TCAs) (e.g., amitriptyline), which can increase the risk of enhanced sedation and severe anticholinergic symptoms.

Other Considerations

Category Potential Interaction/Risk
Anticonvulsants (e.g., Phenytoin) May decrease the rate at which the body eliminates the anticonvulsant, potentially leading to increased drug levels.
Herbal/Dietary Certain supplements like Kava or Valerian root may increase the risk of drowsiness.

Always ensure your doctor or pharmacist is aware of all products you are using to safely manage potential interactions.

Mechanism of Action

How Chlortab Works: Mechanism of Action

Chlortab (chlorpheniramine) exerts its primary action by engaging the Histamine H1 receptor ( H1 R), acting as an inverse agonist and competitive antagonist. This molecular interaction stabilizes the receptor in an inactive conformation, directly preventing histamine from initiating cellular signaling cascades. This peripheral blockade of the histaminergic pathway modulates the effects of histamine on endothelial cells, limiting the histamine-induced increase in vascular permeability and vasodilation, which influences localized fluid dynamics and sensory nerve signaling.

As a lipophilic agent, the drug readily crosses the blood-brain barrier to engage central H1 R. Interference with these central histaminergic pathways leads to the physiological consequence of generalized Central Nervous System (CNS) depression.

Furthermore, the drug exhibits weak affinity for muscarinic acetylcholine receptors. This secondary anticholinergic mechanism acts on exocrine glands, altering glandular secretions and contributing to the systemic fluid dynamics reflected in the drug's overall pharmacological profile.

Dosage and Administration Information

Chlortab (Chlorphenamine Maleate) is administered via the oral route for common use, available in forms such as immediate-release tablets, syrups, and solutions. The medicine is also available as an injectable solution for parenteral administration—specifically intravenous (IV), intramuscular (IM), or subcutaneous (SC) routes—which is typically reserved for acute clinical settings.

The standard administration schedule for the immediate-release oral form is 4 mg every four to six hours, as needed. The maximum daily dose for adults using the immediate-release oral form does not exceed 24 mg within a 24-hour period. For extended-release tablets, dosing follows a less frequent schedule, such as every 8 to 12 hours, with the instruction that the stated dose and frequency must not be exceeded.

Specific administrative protocols apply based on the dosage form. Oral solutions must be measured with an accurate milliliter measuring device; household spoons are not considered adequate for proper dosing. When the intravenous route is employed, the injection is administered slowly over a period of one minute. Furthermore, instructions specify that dosing should be limited to the shortest duration consistent with the clinical objective.

High-level adjustments are specified for certain patient groups. In older adults, a lower maximum daily dose (such as 12 mg per day) and careful consideration of dose frequency are advised, while pediatric dosing is calculated specifically according to the child’s age and weight.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Chlortab

Evidence for Use in Allergic Rhinitis and Acute Allergic Symptoms

The research base for Chlortab includes short-term Randomized Controlled Trials (RCTs) and systematic reviews, exploring the medicine's profile in the context of nasal and ocular allergy symptoms. These studies were used in research exploring how symptoms change over time, and they primarily included adults and adolescents who had confirmed allergic symptoms. The primary outcomes that researchers measured included patient-reported symptom scores (such as the Total Nasal Symptom Score) and measures of health-related quality of life.

Findings describe patterns observed in the studies where trials monitored changes in symptom scores, including those relative to control conditions. Research highlights symptom patterns monitored during the study period, which included reports on oculonasal symptoms during short-term follow-up.

Evidence for Use in Allergic Skin Reactions

The research base was evaluated in studies related to allergic dermatological conditions, including episodic manifestations like hives (urticaria) and generalized itching (pruritus). Studies conducted during periods of increased symptom activity examined outcomes related to physical discomfort. The evidence base includes older controlled trials and systematic reviews that monitored changes in the intensity and frequency of patient-reported itching.

Studies report how symptoms evolved in the observed populations, noting patterns during the short-term observation of acute flare-ups. Research provides insight into short-term changes in these symptoms.

What is Still Uncertain About Chlortab Research

The evidence landscape, while established for its intended uses, includes several areas where certainty remains low or where additional research is needed. Long-term effects are not fully established, as follow-up durations were limited across most efficacy trials. Research provides context but evidence is limited regarding the evolution of chronic conditions. Furthermore, evidence quality varies across studies, with many foundational trials for this older class of medicine predating current high-standard trial design and reporting requirements.

Key Studies & References

  1. Chlorpheniramine Maleate Drug Information (NIH/MedlinePlus)

Frequently Asked Questions (FAQ)

Common questions about Chlortab (FAQ)


Q: How quickly do people usually start to feel the effects of Chlortab?

According to general pharmacological data, the medicine typically begins to take effect within approximately two hours after taking an oral dose. This indicates the typical timeframe for the medicine to begin its effect in the body.

Q: What is the typical duration of effect for a dose of Chlortab?

The effects of an immediate-release dose generally last for approximately four to six hours in most people. This duration is consistent with the general timeframes observed in clinical data for the immediate-release form.

Q: Are there any specific foods or drinks to be generally aware of when using Chlortab?

Regulatory labels indicate that alcoholic beverages should be avoided, as alcohol may increase the effect of drowsiness and sedation caused by Chlortab.

Q: Is Chlortab considered a 'strong' or 'mild' medicine?

Chlortab is officially classified as a first-generation sedating antihistamine. This classification indicates the medicine has a moderate degree of sedative (drowsy) effect, which is a characteristic of this older class of medicine.

Q: What happens if someone forgets to use Chlortab for a day or two?

Official patient guidance notes that taking two doses to compensate for a missed dose should be avoided. Instead, the next dose is generally taken at the usual scheduled time to continue with the regular routine.

Q: Does Chlortab interact with commonly used over-the-counter pain relievers?

Official interactions primarily focus on medicines that also cause drowsiness (CNS depressants) or have anticholinergic effects. Official information indicates that caution is necessary because some over-the-counter cold and flu products containing pain relievers may also include other interacting ingredients like additional antihistamines.

Q: Are there any known issues with combining Chlortab and vitamins or supplements?

Regulatory warnings specifically advise caution when combining Chlortab with certain herbal or dietary supplements. This includes products like Kava or Valerian root, which may increase the risk of drowsiness.

Q: Is Chlortab addictive or habit-forming?

No, Chlortab is not scheduled by the DEA (Drug Enforcement Administration). It is not generally classified as an addictive or habit-forming controlled substance.

Q: Is there a generic version of Chlortab available?

Yes, the active ingredient in Chlortab, chlorpheniramine maleate, is an older compound that is widely available under various generic and store brand labels.

Q: Does the time of day matter when using Chlortab?

The fact that sedation is a very common side effect often results in the medicine being taken in the evening or before sleep. This approach relates to managing the potential interference with daytime activities.

Q: Does taking Chlortab affect driving ability or using machinery?

Yes. Due to the risk of marked drowsiness, regulatory labels explicitly describe the need for caution when driving a motor vehicle or operating machinery. This caution is necessary because of the drug’s effects on the central nervous system.

Q: Are there different strengths of Chlortab, and what do they mean?

Yes, the medication is available in various strengths and release types. Common immediate-release forms are typically 4 mg, while higher strengths (such as 8 mg or 12 mg) are generally used for extended-release formulations.

Q: Is it true that Chlortab can affect blood pressure readings?

While rare, regulatory documentation has noted that adverse effects on the cardiovascular system can include changes like hypotension (low blood pressure) and tachycardia (fast heart rate).

Q: What should a person generally look for if they suspect a medicine interaction with Chlortab?

Interactions may be suspected if there is an increase in common side effects, such as excessive drowsiness, dizziness, or confusion. Official safety information also points to severe signs of anticholinergic effects, such as difficulty passing urine.

Q: What is the main purpose of the inactive ingredients in Chlortab?

Inactive ingredients, which are not medically active, are included to help the drug retain its form, color, or shape. They are also essential in helping the body properly absorb the active ingredient and ensure its stability.

Q: Do regulatory bodies list any specific black box warnings for Chlortab?

Regulatory documents list a variety of serious adverse reactions, such as rare blood disorders and severe allergic reactions. However, the active ingredient, chlorpheniramine maleate, does not typically carry a specific FDA Black Box Warning on its general label.

Q: Can Chlortab be used with common cold and flu medicines?

Labels indicate that caution should be exercised with cold and flu products because many of them already contain an antihistamine or other CNS depressants (drugs that slow brain activity). Combining them may lead to excessive drowsiness or a risk of overdose.

Q: What is the difference between a side effect and an allergic reaction to Chlortab?

Regulatory labels list common side effects like drowsiness as expected undesirable effects of the drug. In contrast, an allergic reaction is a serious type of hypersensitivity, which can include symptoms like swelling or difficulty breathing, and requires immediate medical attention.

Q: Do studies suggest Chlortab is equally effective across different age groups?

Efficacy studies are primarily conducted in adults and adolescents. Because use conditions and maximum doses are specified differently for older adults and children, this implies that the medication’s response or appropriate use may vary across age groups.

Q: Can taking Chlortab cause changes in mood or anxiety levels?

Regulatory documents include reports of psychiatric adverse effects such as mood changes, confusion, irritability, or depression. While these effects are considered rare, they are noted in official adverse effect lists.

Q: Is Chlortab a controlled substance?

No, according to the Drug Enforcement Administration (DEA), Chlortab is not classified as a controlled substance and is not subject to special scheduling requirements.

How should Chlortab be stored and disposed of?

How to Store and Dispose of Chlortab?

Storing Chlortab (Chlorphenamine Maleate) requires adherence to specific regulatory requirements to maintain its stability. The medication must be kept at room temperature, ensuring it is protected from both light and moisture, and never stored above 30 C. To preserve its integrity, keep the medicine in the original container and ensure the lid is tightly closed.

Child Safety and Disposal Rules

Official labeling mandates that Chlortab must be stored out of the sight and reach of children, often requiring the use of locked safety caps. When the product is expired or unused, it should be disposed of through a medicine take-back program or according to local regulations. It must not be thrown into household trash or flushed down a sink or toilet, as this can pose environmental risks. The injectable form, if present, must be used immediately upon opening and any remainder must be discarded.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Chlortab found in:

A-Z Index: